Lama Vibha N, Belperio John A, Christie Jason D, El-Chemaly Souheil, Fishbein Michael C, Gelman Andrew E, Hancock Wayne W, Keshavjee Shaf, Kreisel Daniel, Laubach Victor E, Looney Mark R, McDyer John F, Mohanakumar Thalachallour, Shilling Rebecca A, Panoskaltsis-Mortari Angela, Wilkes David S, Eu Jerry P, Nicolls Mark R
Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
JCI Insight. 2017 May 4;2(9). doi: 10.1172/jci.insight.93121.
Lung transplantation, a cure for a number of end-stage lung diseases, continues to have the worst long-term outcomes when compared with other solid organ transplants. Preclinical modeling of the most common and serious lung transplantation complications are essential to better understand and mitigate the pathophysiological processes that lead to these complications. Various animal and in vitro models of lung transplant complications now exist and each of these models has unique strengths. However, significant issues, such as the required technical expertise as well as the robustness and clinical usefulness of these models, remain to be overcome or clarified. The National Heart, Lung, and Blood Institute (NHLBI) convened a workshop in March 2016 to review the state of preclinical science addressing the three most important complications of lung transplantation: primary graft dysfunction (PGD), acute rejection (AR), and chronic lung allograft dysfunction (CLAD). In addition, the participants of the workshop were tasked to make consensus recommendations on the best use of these complimentary models to close our knowledge gaps in PGD, AR, and CLAD. Their reviews and recommendations are summarized in this report. Furthermore, the participants outlined opportunities to collaborate and directions to accelerate research using these preclinical models.
肺移植作为多种终末期肺病的一种治疗方法,与其他实体器官移植相比,其长期疗效仍然是最差的。对最常见且最严重的肺移植并发症进行临床前建模,对于更好地理解和减轻导致这些并发症的病理生理过程至关重要。目前存在各种肺移植并发症的动物模型和体外模型,且每种模型都有其独特的优势。然而,一些重大问题,如所需的技术专长以及这些模型的稳健性和临床实用性,仍有待克服或阐明。美国国立心肺血液研究所(NHLBI)于2016年3月召开了一次研讨会,以审查针对肺移植三个最重要并发症的临床前科学现状:原发性移植功能障碍(PGD)、急性排斥反应(AR)和慢性肺移植功能障碍(CLAD)。此外,研讨会的参与者被要求就是否能最佳利用这些互补模型以填补我们在PGD、AR和CLAD方面的知识空白达成共识并提出建议。本报告总结了他们的审查结果和建议。此外,参与者还概述了合作机会以及利用这些临床前模型加速研究的方向。